Dexamethasone vs. Dexmedetomidine for Popliteal Nerve Block in Pain Management After Pediatric Ankle and Foot Surgery
Conditions: Foot Injuries and Disorders; Ankle Injuries and Disorders Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Hip Arthroplasty
Conditions: Hip Osteoarthritis; Hip Arthropathy; Hip Pain Chronic Interventions: Drug: 0.9%sodium chloride; Drug: Dexamethasone; Drug: Dexmedetomidine Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Vitrectomy Combined With Intravitreal Dexamethasone Implant for Idiopathic Epiretinal Membrane With Macular Oedema
Conditions: Epiretinal Membrane Interventions: Procedure: vitrectomy combined with intravitreal dexamethasone implant Sponsors: Shanghai Eye Disease Prevention and Treatment Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Conditions: Multiple Myeloma Interventions: Drug: Alnuctamab; Drug: Pomalidomide; Drug: Daratumumab; Drug: Elotuzumab; Drug: Carfilzomib; Drug: Dexamethasone Sponsors: Celgene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
Dexamethasone vs. Dexmedetomidine for ESPB in Pain Management After Spine Surgery
Conditions: Spinal Fusion; Spine Disease; Spinal Stenosis; Erector Spinae Plane Block Interventions: Drug: 0.9% Sodium Chloride Injection; Drug: Dexamethasone 4 Mg/mL Injectable Solution; Drug: Dexmedetomidine injection Sponsors: Poznan University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 31, 2024 Category: Research Source Type: clinical trials
A Trial to Learn How Effective and Safe Odronextamab is Compared to Standard of Care for Adult Participants With Previously Treated Aggressive B-cell Non-Hodgkin Lymphoma
Conditions: B-Cell Non-Hodgkin Lymphoma (B-NHL) Interventions: Drug: Odronextamab; Drug: Ifosfamide; Drug: Carboplatin; Drug: Etoposide; Drug: Rituximab; Drug: Dexamethasone; Drug: Cisplatin; Drug: Cytarabine; Drug: Gemcitabine Sponsors: Regeneron Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Recurrent Multiple Myeloma; Refractory Multiple Myeloma Interventions: Drug: Iberdomide; Biological: Belantamab Mafodotin; Drug: Dexamethasone; Procedure: Echocardiography; Procedure: Computed Tomography; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Procedure: Bone Marrow Biopsy; Procedure: Bone Marrow Aspiration; Procedure: Biospecimen Collection Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials
LAssa Fever Adjunct Treatment With DEXamethasone
Conditions: Lassa Fever Interventions: Drug: Dexamethasone; Drug: Ribavirin Sponsors: Bernhard Nocht Institute for Tropical Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2024 Category: Research Source Type: clinical trials
Iberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma Interventions: Drug: Iberdomide; Drug: Isatuximab; Drug: Dexamethasone Sponsors: University of Heidelberg Medical Center; KKS Netzwerk; Wuerzburg University Hospital; Sanofi; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 22, 2024 Category: Research Source Type: clinical trials
ISTH/ANRS 0409s INTEGRATE Lassa Fever Study
Conditions: Lassa Fever Interventions: Drug: Favipiravir; Drug: Ribavirin; Drug: Dexamethasone Sponsors: Irrua Specialist Teaching Hospital; Alliance for International Medical Action; University of Bordeaux; Bernhard Nocht Institute for Tropical Medicine; Federal Medical Centre, Owo; Programme PAC-CI, Site ANRS-MIE de C ôte d ' Ivoire; Fondation pour la Recherche Scientifique, Benin; M édecins Sans Frontières, Belgium; Alex Ekwueme Federal University Teaching Hospital; Donka Hospital, Conakry; Centre de Recherche Médicale de Lambaréné; University of Hamburg-Eppendorf; Phebe Hospital, Liberia; University of North Caro...
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL)
Conditions: T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma Interventions: Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Drug: Calaspargase Pegol; Procedure: Computed Tomography; Drug: Cyclophosphamide; Drug: Cytarabine; Drug: Daunorubicin; Drug: Dexamethasone; Drug: Doxorubicin; Procedure: Echocardiography; Procedure: Lumbar Puncture; Drug: Mercaptopurine; Drug: Methotrexate; Procedure: Multigated Acquisition Scan; Biological: Navitoclax; Drug: Nelarabine; Drug: Pegaspargase; Procedure: Positron Emission Tomography; Drug: Thioguanine; Drug: Venetoclax; Drug: ...
Source: ClinicalTrials.gov - January 18, 2024 Category: Research Source Type: clinical trials
Instillation of Gentamicin and Dexamethasone in Bronchiectasis Compared to Conventional Treatment
Conditions: Bronchiectasis With Acute Exacerbation Interventions: Drug: bronchoscopic airway clearance followed by local instillation of gentamicin and dexamethasone Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
Conditions: Relapsed or Refractory Multiple Myeloma Interventions: Drug: Talquetamab; Drug: Pomalidomide; Drug: Teclistamab; Drug: Elotuzumab; Drug: Dexamethasone; Drug: Bortezomib Sponsors: Janssen Research& Development, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children
Conditions: Pediatric Solid Tumor, Unspecified, Protocol Specific Interventions: Drug: Ondansetron (Oral soluble film OR injections) ,Dexamethasone Sponsors: Yizhuo Zhang Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
Conditions: Acute Leukemia; Lymphoblastic Leukemia; Lymphoblastic Lymphoma Interventions: Drug: LP-118; Drug: Ponatinib; Drug: Vincristine; Drug: Dexamethasone; Drug: Methotrexate Sponsors: University of Chicago Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2024 Category: Research Source Type: clinical trials
